Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000030826 | SCV001208507 | uncertain significance | Nephronophthisis 14 | 2023-10-22 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 913 of the ZNF423 protein (p.Pro913Leu). This variant is present in population databases (rs200585917, gnomAD 0.03%). This missense change has been observed in individual(s) with nephronophthisis (PMID: 22863007). ClinVar contains an entry for this variant (Variation ID: 37287). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ZNF423 protein function. Experimental studies have shown that this missense change does not substantially affect ZNF423 function (PMID: 22863007, 32925911). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genomic Medicine Center of Excellence, |
RCV000030826 | SCV005438602 | uncertain significance | Nephronophthisis 14 | 2024-12-18 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000030826 | SCV000053501 | pathogenic | Nephronophthisis 14 | 2012-08-03 | no assertion criteria provided | literature only |